Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eltek Q4 EPS $0.14 Down From $0.65 YoY, Sales $10.48M Up From $9.52M YoY

Eltek (NASDAQ:ELTK) reported quarterly earnings of $0.14 per share. This is a 78.46 percent decrease over earnings of $0.65 per share from the same period last year. The company reported $10.48 million in sales this
byBenzinga Newsdesk
March 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Eltek (NASDAQ:ELTK) reported quarterly earnings of $0.14 per share. This is a 78.46 percent decrease over earnings of $0.65 per share from the same period last year. The company reported $10.48 million in sales this quarter. This is a 10.06 percent increase over sales of $9.52 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With B2Gold Stock?

By Erica Kollmann
January 24, 1:04 PM
B2Gold Corp shares are trading lower Wednesday. The company reported its fourth-quarter and full year 2023 consolidated gold production and revenue figures after the market close on Tuesday. B2Gold announced its total consolidated gold production for fourth-quarter at 288,665 ounces, below its consolidated gold production of 367,870 ounces from the same period in 2022.

BTG

Read More

Infection-Focused Barinthus Bio’s VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives

By Vandana Singh
April 19, 11:49 AM
Explore the latest findings from Barinthus Biotherapeutics on VTP-200's performance in the APOLLO trial for low-grade cervical lesions linked to persistent hrHPV infection. Positive trends were noted, though not statistically significant. No major safety concerns were observed.

BRNS